JavaScript is disabled. Please enable to continue!
Mobile search icon
EurofinsUS.com >> Food Testing >> Resource by Keyword
Credible Results. Incredible Service.

Resources

 

Search >>

 

 



This webinar with presenter Joelle Mosso, Associate Chief Scientific Officer for the Eurofins Produce Segment, discusses testing and introduces a new rapid screening tool for enteric pathogens Salmonella and Shiga toxigenic E. coli: EPRITM.


We are proud to share this recently published article authored by Dr. Jean Shoeni, Lead Staff Scientist, Eurofins Microbiology Laboratories, Inc. which provides tools to reduce measurement uncertainty and strengthen the reliability of probiotic enumerations by using analytical procedure lifecycle management (APLM).


January 20, 2022, The Eurofins Microbiology Laboratory network is proud to offer a new approach to risk identification and management, Enteric Pathogen Risk Indicator (EPRI™) testing. This unique screening tool provides a rapid option to screen for Shiga toxigenic E. coli (STEC) and Salmonella in one PCR assay.


New Rapid Pathogen Testing Services. Eurofins Microbiology Laboratories, Inc. is pleased to share our new Enteric Pathogen Risk Indicator (EPRI™) Testing. This new service is a rapid approach to risk identification and management using fast genetic technology (PCR) with the benefits of an indicator test. In addition, we can screen for Salmonella and Shiga toxigenic E. coli at the same time in one assay.


Validation of aseptic fillers intended for the production of low-acid, shelf-stable products is a core requirement of the FDA’s low-acid canned food (LACF) regulations (21CFR113 and 108.35). Microbiological challenges of the aseptic zone and packaging material sterilization cycles are important components of the validation process. These challenges are often conducted at the production site using non-pathogenic surrogate organisms that mimic the resistance of the pertinent target pathogen. This presentation will provide a brief history of the use of such surrogates for the validation of low-acid aseptic fillers along with the approach we have used to qualify the surrogates as adequate for the intended technology.”


 

 

https://www.eurofinsus.com/food-testing